Dermira
Signal active
Organization
Contact Information
Overview
Dermira is a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and their patients. Dermira’s portfolio of five product candidates targets significant market opportunities.
It was founded in 2010 and headquartered in Menlo Park, California.
About
Industries
Biotechnology, Pharmaceutical, Biopharma
Founded
2010
Employees
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Dermira headquartered in United States, North America, operates in the Biotechnology, Pharmaceutical, Biopharma sector. The company focuses on Biotechnology and has secured $176.5B in funding across 156 round(s). With a team of 101-250 employees, Dermira is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Dermira, raised $42.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
13
Investors
3
Lead Investors
0
Total Funding Amount
$1131.4M
Details
3
Dermira has raised a total of $1131.4M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2014 | Late Stage Venture | 51.0M | ||
| 2013 | Early Stage Venture | 35.0M | ||
| 2011 | Early Stage Venture | 42.0M |
Investors
Dermira is funded by 24 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| New Enterprise Associates | - | FUNDING ROUND - New Enterprise Associates | 35.0M |
| Wende Hutton | - | FUNDING ROUND - Wende Hutton | 35.0M |
| Dermira | - | FUNDING ROUND - Dermira | 35.0M |
| Canaan Partners | - | FUNDING ROUND - Canaan Partners | 35.0M |
Recent Activity
There is no recent news or activity for this profile.